The next step is a detailed conversation
Current NHS eligibility criteria for semaglutide 2.4 mg (Wegovy) for weight management, according to NICE TA875, include: Body Mass Index (BMI) 35 kg/m with at least one weight-related comorbidity (such as type 2 diabetes, hypertension, dyslipidaemia, obstructive sleep apnoea) For people from certain high-risk ethnic groups (such as South Asian, Chinese, Black African, or African-Caribbean), lower BMI thresholds apply (typically reduced by 2.5 kg/m) Treatment must be prescribed within specialist weight management services only Treatment is limited to a maximum duration of 2 years Must be used as an adjunct to a reduced-calorie diet and increased physical activity Liraglutide 3 mg (Saxenda) availability varies significantly across NHS regions and is not routinely commissioned in many areas
Healthy habits can help reduce that effect: Prioritize protein Stay active with strength training and exercise Monitor calorie intake Build sustainable routines For individuals who have lost a significant amount of weight (especially 50+ pounds), some form of ongoing weight management treatment may be helpful to maintain results long term
At the end of the day, a qualified healthcare provider is your most valuable resource for determining whats best for you, your health, and your goals
Its the hormone thats suddenly a household name, thanks to weight-loss meds like Ozempic and Wegovy
